The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...

Despite its government spending more than any other on health care both per capita and as a percentage of GDP, spending over $4.5 trillion in 2022, the United States has the lowest life expectancy at ...

Boosts Natural Energy Using natural stimulants like Guarana and Maca Root, Free Sugar Pro enhances energy levels without dependency. These ingredients support sustained physical and mental energy, ...

Eleuthero Also known as Siberian ginseng, Eleuthero is an adaptogen that helps the body handle stress and maintain balance. It boosts stamina and mental performance while supporting blood sugar ...

The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.

Oklahoma City Police have released new body cam and dash cam footage showing the moments after an alleged carjacking lead to ...

A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for widely used prescription drugs was revived by a federal appeals ...

The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...

FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.

The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...

The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.

FTC's action today is likely only the tip of the iceberg of necessary reforms to end PBMs' harmful business practices that have directly led to the lights going out for thousands of independent ...